- Home
- COE vs LYEL Comparison
COE vs LYEL Comparison
Compare COE & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COE
- LYEL
- Stock Information
- Founded
- COE 2011
- LYEL 2018
- Country
- COE Singapore
- LYEL United States
- Employees
- COE N/A
- LYEL N/A
- Industry
- COE Other Consumer Services
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- COE Real Estate
- LYEL Health Care
- Exchange
- COE Nasdaq
- LYEL Nasdaq
- Market Cap
- COE 177.0M
- LYEL 207.7M
- IPO Year
- COE 2016
- LYEL 2021
- Fundamental
- Price
- COE $28.72
- LYEL $9.84
- Analyst Decision
- COE
- LYEL Sell
- Analyst Count
- COE 0
- LYEL 2
- Target Price
- COE N/A
- LYEL $15.00
- AVG Volume (30 Days)
- COE 20.4K
- LYEL 148.8K
- Earning Date
- COE 08-22-2025
- LYEL 08-06-2025
- Dividend Yield
- COE N/A
- LYEL N/A
- EPS Growth
- COE N/A
- LYEL N/A
- EPS
- COE N/A
- LYEL N/A
- Revenue
- COE $59,490,000.00
- LYEL $65,000.00
- Revenue This Year
- COE N/A
- LYEL N/A
- Revenue Next Year
- COE N/A
- LYEL N/A
- P/E Ratio
- COE N/A
- LYEL N/A
- Revenue Growth
- COE 91.87
- LYEL N/A
- 52 Week Low
- COE $11.84
- LYEL $7.65
- 52 Week High
- COE $34.74
- LYEL $38.40
- Technical
- Relative Strength Index (RSI)
- COE 51.58
- LYEL 52.64
- Support Level
- COE $27.98
- LYEL $9.11
- Resistance Level
- COE $31.50
- LYEL $10.41
- Average True Range (ATR)
- COE 2.40
- LYEL 0.61
- MACD
- COE -0.70
- LYEL 0.04
- Stochastic Oscillator
- COE 21.31
- LYEL 70.77
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.